Company Filing History:
Years Active: 2015
Title: **Okey Noe: Innovator in Pharmaceutical Formulations**
Introduction
Okey Noe, an accomplished inventor based in Morgantown, West Virginia, has made significant contributions to the field of pharmaceuticals. His focus on innovative formulations has the potential to improve the treatment of medical conditions such as hyperphosphatemia, showcasing the importance of research and development in healthcare.
Latest Patents
Okey Noe holds a patent for “Disintegrable formulations of lanthanum carbonate.” This invention involves disintegrable preparations of lanthanum carbonate that are produced via co-precipitation. The technology facilitates the manufacture of various oral pharmaceutical dosage forms, including tablets, capsules, powders, granules, and sprinkles. These dosage forms can be effectively used to treat patients suffering from hyperphosphatemia, marking a significant advancement in pharmaceutical applications.
Career Highlights
Okey Noe is affiliated with Mylan Pharmaceuticals Inc., a notable company in the pharmaceutical industry known for its commitment to ensuring access to high-quality medicines. His work at Mylan Pharmaceuticals reflects a dedication to innovative healthcare solutions, emphasizing both the efficacy and safety of pharmaceutical treatments.
Collaborations
Throughout his career, Okey Noe has collaborated with esteemed colleagues such as Andrea Blum Works and John Twist. These partnerships contribute to a vibrant exchange of ideas and expertise, further enhancing the potential for breakthroughs in pharmaceutical technology.
Conclusion
Okey Noe exemplifies the spirit of innovation within the pharmaceutical industry. His patent for disintegrable formulations of lanthanum carbonate not only addresses a critical need in treating hyperphosphatemia but also highlights the importance of collaboration and research in achieving significant health outcomes. As industry trends evolve, inventors like Okey Noe will continue to drive advancements that ultimately benefit patients worldwide.